Nerve injury

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Nerve injury
Endoneurial fibrosis - very high mag - cropped.jpg
Micrograph of a nerve with a decrease in myelinated nerve fibres (pink) and an abnormal increase in fibrous tissue (yellow), as may be seen in nerve injuries. HPS stain.
Classification and external resources
Specialty emergency medicine
ICD-10 T14.4

Nerve injury is injury to nervous tissue. There is no single classification system that can describe all the many variations of nerve injury. In 1941, Seddon introduced a classification of nerve injuries based on three main types of nerve fiber injury and whether there is continuity of the nerve.[1] Usually, however, (peripheral) nerve injury is classified in five stages, based on the extent of damage to both the nerve and the surrounding connective tissue, since supporting glial cells may be involved. Unlike in the central nervous system, neuroregeneration in the peripheral nervous system is possible.[2] The processes that occur in peripheral regeneration can be divided into the following major events: Wallerian degeneration, axon regeneration/growth, and nerve reinnervation. The events that occur in peripheral regeneration occur with respect to the axis of the nerve injury. The proximal stump refers to the end of the injured neuron that is still attached to the neuron cell body; it is the part that regenerates. The distal stump refers to the end of the injured neuron that is still attached to the end of the axon; it is the part of the neuron that will degenerate but that remains in the area toward which the regenerating axon grows. The study of peripheral nerve injury began during the American Civil War and has greatly expanded to the point of using growth-promoting molecules.[3]

Types[edit]

Neuropraxia[edit]

This is the least severe form of nerve injury, with complete recovery. In this case, the axon remains intact, but there is myelin damage causing an interruption in conduction of the impulse down the nerve fiber. Most commonly, this involves compression of the nerve or disruption to the blood supply (ischemia). There is a temporary loss of function which is reversible within hours to months of the injury (the average is 6–9 weeks). Wallerian degeneration does not occur, so recovery does not involve actual regeneration. There is frequently greater involvement of motor than sensory function with autonomic function being retained. In electrodiagnostic testing with nerve conduction studies, there is a normal compound motor action potential amplitude distal to the lesion at day 10, and this indicates a diagnosis of mild neuropraxia instead of axonotmesis or neurotmesis.[4]

Axonotmesis[edit]

This is a more severe nerve injury with disruption of the neuronal axon, but with maintenance of the epineurium. This type of nerve damage may cause paralysis of the motor, sensory, and autonomic. Mainly seen in crush injury.

If the force creating the nerve damage is removed in a timely fashion, the axon may regenerate, leading to recovery. Electrically, the nerve shows rapid and complete degeneration, with loss of voluntary motor units. Regeneration of the motor end plates will occur, as long as the endoneural tubules are intact.

Axonotmesis involves loss of the relative continuity of the axon and its covering of myelin,[clarification needed] but preservation of the connective tissue framework of the nerve ( the encapsulating tissue, the epineurium and perineurium, are preserved ). Because axonal continuity is lost, Wallerian degeneration occurs. Electromyography ( EMG ) performed 2 to 4 weeks later shows fibrillations and denervation potentials in musculature distal to the injury site. Loss in both motor and sensory spines is more complete with axonotmesis than with neurapraxia, and recovery occurs only through regenerations of the axons, a process requiring time.

Axonotmesis is usually the result of a more severe crush or contusion than neurapraxia, but can also occur when the nerve is stretched (without damage to the epineurium). There is usually an element of retrograde proximal degeneration of the axon, and for regeneration to occur, this loss must first be overcome. The regeneration fibers must cross the injury site and regeneration through the proximal or retrograde area of degeneration may require several weeks. Then the neuritis tip progresses down the distal site, such as the wrist or hand. Proximal lesion may grow distally as fast as 2 to 3 mm per day and distal lesion as slowly as 1.5 mm per day. Regeneration occurs over weeks to years.

Neurotmesis[edit]

Neurotmesis is the most severe lesion with no potential of full recovery. It occurs on severe contusion, stretch, laceration, or Local Anesthetic Toxicity. The axon and encapsulating connective tissue lose their continuity. The last (extreme) degree of neurotmesis is transsection, but most neurotmetic injuries do not produce gross loss of continuity of the nerve but rather internal disruption of the architecture of the nerve sufficient to involve perineurium and endoneurium as well as axons and their covering. Denervation changes recorded by EMG are the same as those seen with axonotmetic injury. There is a complete loss of motor, sensory and autonomic function. If the nerve has been completely divided, axonal regeneration causes a neuroma to form in the proximal stump. For neurotmesis, it is better to use a new more complete classification called the Sunderland System.

Overview of events in peripheral regeneration[edit]

Wallerian degeneration is a process that occurs before nerve regeneration and can be described as a cleaning or clearing process that essentially prepares the distal stump for reinnervation. Schwann cells are glial cells in the peripheral nervous system that support neurons by forming myelin that encases nerves. During Wallerian degeneration Schwann cells and macrophages interact to remove debris, specifically myelin and the damaged axon, from the distal injury site. (medscape) Calcium has a role in the degeneration of the damage axon. Bands of Büngner are formed when un-innervated Schwann cells proliferate and the remaining connective tissue basement membrane forms endoneurial tubes. Bands of Büngner are important for guiding the regrowing axon.[3]

At the neuronal cell body, a process called chromatolysis occurs in which the nucleus migrates to the periphery of the cell body and the endoplasmic reticulum breaks up and disperses. Nerve damage causes the metabolic function of the cell to change from that of producing molecules for synaptic transmission to that of producing molecules for growth and repair. These factors include GAP-43, tubulin and actin. Chromatolysis is reversed when the cell is prepared for axon regeneration.[5]

Axon regeneration is characterized by the formation of a growth cone. The growth cone has the ability to produce a protease that digests any material or debris that remains in its path of regeneration toward the distal site. The growth cone responds to molecules produced by Schwann cells such as laminin and fibronectin.[3]

Role of Schwann cells[edit]

Guillain–Barré syndrome – nerve damage

Schwann cells are active in Wallerian degeneration. They not only have a role in phagocytosis of myelin, but they also have a role in recruitment of macrophages to continue the phagocytosis of myelin. The phagocytic role of Schwann cells has been investigated by studying the expression of molecules in Schwann cells that are typically specific to inflammatory macrophages. Expression of one such molecule MAC-2, a galactose-specific lectin, is observed in not only degenerating nerves that are macrophage-rich but also degenerating nerves that are macrophage-scarce and Schwann cell-rich. Furthermore, the effects of MAC-2 in degenerating nerves are associated with myelin phagocytosis. There was a positive correlation between the amount of MAC-2 expression and the extent of myelin phagocytosis. A deficiency in MAC-2 expression can even cause inhibition of myelin removal from injury sites.[6]

Schwann cells are active in demylenation of injured nerves before macrophages are even present at the site of nerve injury. Electron microscopy and immunohistochemical staining analysis of teased nerve fibers shows that before macrophages arrive at the injury site, myelin is fragmented and myelin debris and lipid droplets are found in the cytoplasm of Schwann cells, indicating phagocytic activitiy before macrophages arrive.[7]

Schwann cell activity includes recruitment of macrophages to the injury site. Monocyte chemoattractant protein (MCP-1) plays a role in recruiting monocytes/macrophages. In tellurium-induced demylenation with no axon degeneration, nerve crush with axon degeneration, and nerve transection with axon degeneration an increase in MCP-1 mRNA expression followed by an increase in macrophage recruitment occurred. In addition varying levels of MCP-1 mRNA expression also had an effect. Increased MCP-1 mRNA levels correlated positively with an increase in macrophage recruitment. Furthermore, in situ hybridation determined that the cellular source of MCP-1 was Schwann cells.[8]

Schwann cells play an important role in not only producing neurotrophic factors such as nerve growth factor (NGF) and ciliary neurotrophic factor (CNTF), which promote growth, of both the damaged nerve and supporting Schwann cells, but also producing neurite promoting factors, which guide the growing axon, both of which are discussed below.

Role of macrophages[edit]

The primary role of macrophages in peripheral regeneration is demylenation during Wallerian degeneration. Immunohistochemical analysis showed that in tellurium demylenated, crushed, and cut nerves, expression of lysozyme, which is a marker for myelin phagocytosis, and of ED1, which is a marker for macrophages, occurred in the same region. Lysozyme was also investigated with respect to the temporal progression of myelin phagocytosis by macrophages in nerve injury. Northern blotting showed that peak lysozyme mRNA expression occurred at an appropriate time with respect to temporal models of myelin phagocytosis. Macrophages do not phagocytose all cellular debris at the nerve injury site; they are selective and will salvage certain factors. Macrophages produce apolipoprotien E which is involved in rescuing cholesterol in damaged nerves. In the same investigation, temporal levels of apolipoprotein E mRNA expression in the three models for demylenation and nerve damage were consistent with respect to models for cholesterol salvage in nerve injury. Macrophages play a role in salvaging cholesterol during nerve injury.[9]

Macrophages also play a role in inducing the proliferation of Schwann cells that occurs during Wallerian degeneration. Supernatant has been collected from medium in which macrophages are active in myelin phagocytosis where lysosomal processing of the myelin occurs within the macrophage. The supernatant contains a mitogenic factor, a mitosis promoting factor, that is characterized heat and trypsin sensitivity, both of which characterize it as a peptide. Treatment of Schwann cells with the collected supernatant shows that it is a mitogenic factor and thus plays an important role in the proliferation of Schwann cells.[10]

Macrophages are also involved in the secretion factors that promote nerve regeneration. Macrophages secrete not only interleukin-1, a cytokine that induces expression of nerve growth factor (NGF) in Schwann cells but also an interleukin-1 receptor antagonist (IL-1ra). Expression of IL-1ra in mice with transected sciatic nerves via implantation of a tube releasing IL-1ra showed the regrowth of fewer myelinated and unmyelinated axons. Macrophage secretion of interleukin-1 is involved in stimulation of nerve regeneration.[11]

Role of neurotrophic factors[edit]

Neurotrophic factors are those that promote survival and growth of neurons. A trophic factor can be described as a factor that is associated with providing nourishment to allow for growth. In general they are protein ligands for tyrosine kinase receptors; binding to the specific receptor yields autophosphorylation and subsequent phosphorylation of tyrosine residues on proteins that participate in further downstream signaling to activate proteins and genes involved in growth and proliferation. Neurotrophic factors act through retrograde transport in neurons, in which they are taken up by the growth cone of the injured neuron and transported back to the cell body.[5][12]

Nerve growth factor (NGF) typically has a low level of expression in nerves that are healthy and not growing or developing, but in response to nerve injury NGF expression increases in Schwann cells. This is a mechanism to increase growth and proliferation of Schwann cells at the distal stump in order to prepare for reception of the regenerating axon. NGF has not only a trophic role but also a tropic or guiding role. The Schwann cells that form the bands of Bungner at the distal injury site express NGF receptors as a guiding factor for the regenerating axon of the injured neuron. NGF bound to the receptors on Schwann cells provides the growing neurons that are contacted with a trophic factor to promote further growth and regeneration[3][5][12]

Ciliary neurotrophic factor (CNTF) typically has a high level of expression in Schwann cells associated with nerves that are healthy, but in response to nerve injury CNTF expression decreases in Schwann cells distal to the injury site and remains relatively low unless the injured axon begins to regrow. CNTF has numerous trophic roles in motor neurons in the peripheral nervous system including the prevention of atrophy of dennervated tissue and the prevention of degeneration and death of motor neurons after nerve injury. (frostick) In sciatic motor neurons both CNTF receptor mRNA expression and CNTF receptor is increased after injury for a prolonged time frame compared to the short time frame in the central nervous system suggesting a role for CNTF in nerve regeneration.[13]

Insulin-like growth factors (IGFs) have been shown to increase the rate of peripheral nervous system axon regeneration. IGF-I and IGF-II mRNA levels are significantly increased distal to the site of crush injury in rat sciatic nerves.[14] At the site of nerve repair, locally delivered IGF-I can significantly increase the rate of axon regeneration within a nerve graft and help expedite functional recovery of a paralyzed muscle.[15][16]

Role of neurite-promoting factors[edit]

Neurite promoting factors include many extracellular matrix proteins produced by Schwann cells at the distal stump including fibronectin and laminin. Fibronectin are components of the basal lamina and promote neurite growth and adhesion of the growth cone to the basal lamina. In regenerating neural cells, neurite promoting factors play a role in adhesion of the axon and include neural cell adhesion molecule (N-CAM) and N-cadherin.[17]

Nerve regeneration therapies[edit]

Electrical stimulation can promote nerve regeneration[citation needed]. The frequency of stimulation is an important factor in the success of both quality and quantity of axon regeneration as well as growth of the surrounding myelin and blood vessels that support the axon. Histological analysis and measurement of regeneration showed that low frequency stimulation had a more successful outcome than high frequency stimulation on regeneration of damaged sciatic nerves.[18]

Surgery can be done in case a nerve has become cut or otherwise divided. Recovery of a nerve after surgical repair depends mainly on the age of the patient. Young children can recover close-to-normal nerve function.[19] In contrast, a patient over 60 years old with a cut nerve in the hand would expect to recover only protective sensation, that is, the ability to distinguish hot/cold or sharp/dull.[19] Many other factors also affect nerve recovery.[19] The use of autologous nerve grafting procedures that involve redirection of regenerative donor nerve fibers into the graft conduit has been successful in restoring target muscle function. Localized delivery of soluble neurotrophic factors may help promote the rate of axon regeneration observed within these graft conduits.[20]

An expanding area of nerve regeneration research deals with the development of scaffolding and bio-conduits. Scaffolding developed from biomaterial would be useful in nerve regeneration if they successfully exhibit essentially the same role as the endoneurial tubes and Schwann cell do in guiding regrowing axons.[21]


See also[edit]

References[edit]

  1. ^ Seddon, H.J.: Classification of nerve injuries, British Medical Journal, 2:237, 1942.
  2. ^ Fenrich, Keith; Gordon, Tessa (2004). "Axonal Regeneration in the Peripheral and Central Nervous Systems - Current Issues and Advances". Canadian Journal of Neurological Sciences. 31 (2): 142–156. ISSN 0317-1671. 
  3. ^ a b c d Campbell, William W. (31 August 2008). "Evaluation and management of peripheral nerve injury". Clinical Neurophysiology. 119 (9): 1951–1965. PMID 18482862. doi:10.1016/j.clinph.2008.03.018. 
  4. ^ Faubel, C: Nerve Injury Classifications – Seddon’s and Sunderland’s. www.ThePainSource.com, 2010.
  5. ^ a b c Burnett, Mark G.; Zager, Eric L. (2004). "Pathophysiology of Peripheral Nerve Injury: A Brief Review". Medscape Today: Neurosurgical Focus. ISSN 1092-0684. Retrieved 11 August 2013. 
  6. ^ Reichert, F; Saada, A; Rotshenker, S (May 1994). "Peripheral nerve injury induces Schwann cells to express two macrophage phenotypes: phagocytosis and the galactose-specific lectin MAC-2.". The Journal of neuroscience : the official journal of the Society for Neuroscience. 14 (5 Pt 2): 3231–45. PMID 8182468. 
  7. ^ Stoll, G.; Griffin, J. W.; Li, C. Y.; Trapp, B. D. (1 October 1989). "Wallerian degeneration in the peripheral nervous system: participation of both Schwann cells and macrophages in myelin degradation". Journal of Neurocytology. 18 (5): 671–683. PMID 2614485. doi:10.1007/BF01187086. 
  8. ^ Toews, Arrel D.; Barrett, Cheri; Morell, Pierre (15 July 1998). "Monocyte chemoattractant protein 1 is responsible for macrophage recruitment following injury to sciatic nerve". Journal of Neuroscience Research. 53 (2): 260–267. PMID 9671983. doi:10.1002/(SICI)1097-4547(19980715)53:2<260::AID-JNR15>3.0.CO;2-A. 
  9. ^ Venezie, R. D.; Toews, A. D.; Morell, Pierre (1 January 1995). "Macrophage recruitment in different models of nerve injury: Lysozyme as a marker for active phagocytosis". Journal of Neuroscience Research. 40 (1): 99–107. PMID 7714930. doi:10.1002/jnr.490400111. 
  10. ^ Baichwal,, R. R.; Bigbee, J. W.; Devries, G. H. (1988). "Macrophage-mediated myelin-related mitogenic factor for cultured Schwann cells.". Neurobiology. 85: 1701–1705. JSTOR 31299. PMC 279842Freely accessible. PMID 3422757. doi:10.1073/pnas.85.5.1701. 
  11. ^ Guénard, V; Dinarello, CA; Weston, PJ; Aebischer, P (July 1991). "Peripheral nerve regeneration is impeded by interleukin-1 receptor antagonist released from a polymeric guidance channel.". Journal of neuroscience research. 29 (3): 396–400. PMID 1833560. doi:10.1002/jnr.490290315. 
  12. ^ a b Frostick, Simon P.; Yin, Qi; Kemp, Graham J. (1 January 1998). "Schwann cells, neurotrophic factors, and peripheral nerve regeneration". Microsurgery. 18 (7): 397–405. PMID 9880154. doi:10.1002/(SICI)1098-2752(1998)18:7<397::AID-MICR2>3.0.CO;2-F. 
  13. ^ MacLennan, AJ; Devlin, BK; Neitzel, KL; McLaurin, DL; Anderson, KJ; Lee, N (1999). "Regulation of ciliary neurotrophic factor receptor alpha in sciatic motor neurons following axotomy.". Neuroscience. 91 (4): 1401–13. PMID 10391446. doi:10.1016/S0306-4522(98)00717-9. 
  14. ^ Glazner, Gordon W.; Morrison, Andrew E.; Ishii, Douglas N. (31 August 1994). "Elevated insulin-like growth factor (IGF) gene expression in sciatic nerves during IGF-supported nerve regeneration". Molecular Brain Research. 25 (3–4): 265–272. PMID 7808226. doi:10.1016/0169-328X(94)90162-7. 
  15. ^ Tiangco, David A.; Papakonstantinou, Konstantinos C.; Mullinax, Kelly A.; Terzis, Julia K. (1 January 2001). "IGF-I and End-to-Side Nerve Repair: A Dose-Response Study". Journal of Reconstructive Microsurgery. 17 (04): 247–256. PMID 11396586. doi:10.1055/s-2001-14516. 
  16. ^ Fansa, Hisham; Schneider, Wolfgang; Wolf, Gerald; Keilhoff, Gerburg (1 July 2002). "Influence of insulin-like growth factor-I (IGF-I) on nerve autografts and tissue-engineered nerve grafts". Muscle & Nerve. 26 (1): 87–93. PMID 12115953. doi:10.1002/mus.10165. 
  17. ^ Seckel, Brooke R. (1 September 1990). "Enhancement of peripheral nerve regeneration". Muscle & Nerve. 13 (9): 785–800. PMID 2233865. doi:10.1002/mus.880130904. 
  18. ^ Lu, M.-C.; Ho, C.-Y.; Hsu, S.-F.; Lee, H.-C.; Lin, J.-H.; Yao, C.-H.; Chen, Y.-S. (11 December 2007). "Effects of Electrical Stimulation at Different Frequencies on Regeneration of Transected Peripheral Nerve". Neurorehabilitation and Neural Repair. 22 (4): 367–373. PMID 18663248. doi:10.1177/1545968307313507. 
  19. ^ a b c The Southern Orthopaedic Association > Patient Education: Nerve Repair and Grafting in the Upper Extremity 2006. Retrieved on Jan 12, 2009
  20. ^ Thanos, PK; Okajima, S; Tiangco, DA; Terzis, JK (1999). "Insulin-like growth factor-I promotes nerve regeneration through a nerve graft in an experimental model of facial paralysis.". Restorative neurology and neuroscience. 15 (1): 57–71. PMID 12671244. 
  21. ^ Fansa, H; Keilhoff, G (March 2004). "Comparison of different biogenic matrices seeded with cultured Schwann cells for bridging peripheral nerve defects.". Neurological research. 26 (2): 167–73. PMID 15072636. doi:10.1179/016164104225013842.